Patients taking blockbuster obesity drugs Ozempic or Wegovy will pack the pounds back on after they stop taking the medications. “I think this is what we see when people go on diets or different exercise regimens, similar to when they go on a pharmacological treatment,” Karin Conde-Knape, Novo Nordisk’s senior vice president of global drug discovery, said in an interview at CNBC’s Healthy Returns Summit on Wednesday. “As long as you’re keeping your intake the same, your output the same, you’r...